Shin Nippon Biomedical Laboratories, Ltd. Financial Overview
Shin Nippon Biomedical Laboratories, Ltd.'s market cap is currently ¥77.14B. The company's EPS TTM is ¥19.23; its P/E ratio is 16.57; and it has a dividend yield of 2.70%. Shin Nippon Biomedical Laboratories, Ltd. is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
